Related Experiment Video

Updated: Jun 5, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Hybrid coronary revascularization: an overview of options for anticoagulation and platelet inhibition

David Zimrin1, Johannes Bonatti, Mark R Vesely

  • 1Division of Cardiology and Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD, USA. dzimrin@medicine.umaryland.edu

The Heart Surgery Forum
|December 21, 2010
PubMed

Insights

Hybrid coronary revascularization combines surgery and stenting for coronary artery disease. Optimal antiplatelet and anticoagulant therapy selection is crucial to balance bleeding and thrombosis risks for each patient.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Hybrid coronary revascularization (HCR) integrates coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI).
  • HCR aims to optimize outcomes in coronary artery disease (CAD) management.
  • Balancing surgical bleeding risk against PCI-related thrombosis risk is a key challenge in HCR.

Purpose of the Study:

  • To review the advantages and disadvantages of current antiplatelet and anticoagulant agents used in HCR.
  • To inform optimal pharmacologic strategies for HCR procedures.

Main Methods:

  • Review of current antiplatelet and anticoagulant medications.
  • Analysis of their efficacy and safety profiles in the context of HCR.

Main Results:

  • Available anticoagulants and antiplatelet agents can provide effective thrombosis protection while minimizing bleeding in HCR.
  • No universal optimal strategy exists; patient-specific pharmacologic and logistic considerations are paramount.

Conclusions:

  • Understanding the characteristics of available medications is essential for tailoring HCR strategies.
  • Cardiologists and surgeons must collaborate to design individualized treatment plans for optimal patient outcomes.
Abstract

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...